Ovid Therapeutics Statistics

Total Valuation

OVID has a market cap or net worth of $74.92 million. The enterprise value is $26.21 million.

Market Cap	74.92M
Enterprise Value	26.21M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

OVID has 71.01 million shares outstanding. The number of shares has increased by 0.42% in one year.

Current Share Class	71.01M
Shares Outstanding	71.01M
Shares Change (YoY)	+0.42%
Shares Change (QoQ)	-0.32%
Owned by Insiders (%)	5.21%
Owned by Institutions (%)	36.39%
Float	46.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	116.61
Forward PS	9.60
PB Ratio	0.97
P/TBV Ratio	0.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	41.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.66, with a Debt / Equity ratio of 0.20.

Current Ratio	5.66
Quick Ratio	5.39
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.61% and return on invested capital (ROIC) is -39.27%.

Return on Equity (ROE)	-36.61%
Return on Assets (ROA)	-36.04%
Return on Capital (ROIC)	-39.27%
Revenue Per Employee	$15,792
Profits Per Employee	-$812,549
Employee Count	40
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.64% in the last 52 weeks. The beta is 0.41, so OVID's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-68.64%
50-Day Moving Average	1.16
200-Day Moving Average	2.01
Relative Strength Index (RSI)	36.02
Average Volume (20 Days)	248,290

Short Selling Information

The latest short interest is 679,890, so 0.96% of the outstanding shares have been sold short.

Short Interest	679,890
Short Previous Month	606,846
Short % of Shares Out	0.96%
Short % of Float	1.46%
Short Ratio (days to cover)	7.01

Income Statement

In the last 12 months, OVID had revenue of $631,695 and -$32.50 million in losses. Loss per share was -$0.46.

Revenue	631,695
Gross Profit	631,695
Operating Income	-65.65M
Pretax Income	-50.68M
Net Income	-32.50M
EBITDA	-65.06M
EBIT	-65.65M
Loss Per Share	-$0.46

Full Income Statement

Balance Sheet

The company has $62.71 million in cash and $15.08 million in debt, giving a net cash position of $47.64 million or $0.67 per share.

Cash & Cash Equivalents	62.71M
Total Debt	15.08M
Net Cash	47.64M
Net Cash Per Share	$0.67
Equity (Book Value)	76.29M
Book Value Per Share	1.07
Working Capital	54.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$57.86 million and capital expenditures -$62,308, giving a free cash flow of -$57.92 million.

Operating Cash Flow	-57.86M
Capital Expenditures	-62,308
Free Cash Flow	-57.92M
FCF Per Share	-$0.82

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-10,392.91%
Pretax Margin	-5,145.20%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-10,643.44%

Dividends & Yields

OVID does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.42%
Shareholder Yield	-0.42%
Earnings Yield	-44.01%
FCF Yield	-78.43%

Analyst Forecast

The average price target for OVID is $4.04, which is 282.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.04
Price Target Difference	282.94%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	183.67%
EPS Growth Forecast (5Y)	-10.82%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OVID has an Altman Z-Score of -1.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.25
Piotroski F-Score	1